The chronic fatigue syndrome;Das chronische Erschopfbarkeitssyndrom (chronic-fatigue-syndrom)

Aktuelle Neurologie

Volumn 25, Issue 1, 1998, Pages 6-12

  Nix, W A ^a   Egle, U T ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDIASIS; CHRONIC DISEASE; CHRONIC FATIGUE SYNDROME; DIAGNOSTIC TEST; ENVIRONMENTAL FACTOR; FIBROMYALGIA; HUMAN; MULTIPLE CHEMICAL SENSITIVITY; REVIEW; SICK BUILDING SYNDROME;

EID: 0031885023     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1017656     Document Type: Review

References (94)

1. Abbey, S. E., P. E. Garfinkel: Neurasthenia and chronic fatigue syndrome: the role of culture in the making of a diagnosis. Am. J. Psychiatry 148 (1991) 1638-1646
2. Acheson, E.D.: The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland diseases and epidemic neuromyasthenie. Am. J. Med. 26 (1959) 569-595
3. Barnes, P. R., D. J. Taylor, C. J. Kemp et al.: Skeletal muscle bioenergetics in the chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 56 (1993) 679-683
4. Bates, D. W., W. Schmitt, D. Buchwald, et al.: Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch. Intern. Med. 153 (1993) 2759-2765
5. Beard, G.: American Nervousness. GP Putnam, New York (1881)
6. Behan, P. O., W. M. Behan, J. W. Gow, et al.: Enteroviruses and postviral fatigue syndrome, Ciba Found. Symp. 173 (1993) 146-154; discussion 154-159
7. Behan, P.O., W. M. Behan, D. Horrobin: Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol. Scand. 82 (1990) 209-216
8. Bowles, N. E., T. A. Bayston, H. Y. Zhang et al.: Persistence of enterovirus RNA in muscle biopsy samples suggests that some cases of chronic fatigue syndrome result from a previous, inflammatory viral myopathy. J. Med. 24 (1993) 145-60
9. Brouwer, B., T. Packer: Corticospinal excitability in patients diagnosed with chronic fatigue syndrome. Muscle & Nerve 17 (1994) 1210-1212
10. Buchwald, D., P. R. Cheney, D. L. Peterson et al.: A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann. Intern. Med. 116 (1992) 103-113
11. Buchwald, D., D. Garrity: Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch. Intern. Med. 154 (1994) 2049-2053
12. Buchwald, D., J. L. Sullivan, A. L. Komaroff: Frequency of 'chronic active Epstein-Barr virus infection' in a general medical practice. JAMA 257 (1987) 2303-2307
13. Buchwald, D., P. Umali, J. Umali et al.: Chronic fatigue and the chronic fatigue syndrome: Prevalence in a pacific northwest health care system. Ann. Intern. Med. 123 (1995) 81-88
14. Burkhard, B.: Unkonventionelle Konzepte in der Umweltmedizin. Versicherungsmedizin 48 (1996) 179-184
15. Butler, S., T. Chalder, M. Ron et al.: Cognitive behaviour therapy in chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 54 (1991) 153-158
16. Byrne, E., I. Trounce: Chronic fatigue and myalgia syndrome: Mitochondrial and glycolytic studies in skeletal muscle. J. Neurol. Neurosurg. Psychiatry 50 (1987) 743-746
17. Cathebras, P., J. Robbins, L. Kirmayer et al.: Fatigue in primary care: Prevalence, psychiatric comorbidity, illness behaviour and outcome. J. Gen. Intern. Med. 7 (1992) 276-286
18. Clark, M.R., W. J. Katon, J. Russo et al.: Chronic fatigue: Risk factors for symptom persistence in a 2 1/2-Year follow-up study. Am. J. Med. 98 (1995) 187-195
19. Cluff, L.E., A. Canter, J. B. Imboden: Asian influenza: Infection, disease and psychological factors. Arch. Intern. Med. 117 (1966) 159-163
20. Cope, H., A. S. David: Neuroimaging in chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 60 (1996) 471-473
21. Cope, H., A. Pernet, B. Kendall et al.: Cognitive functioning and magnetic resonance imaging in chronic fatigue. Br. J. Psychiatry 167 (1995) 86-94
22. Costa, D.C., C. Tannock, J. Brostoff: Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 88 (1995) 767-773
23. Coyle, P.K., L B. Krupp, C. Doscher et al.: Borrelia Burgdorferi reactivity in patients with severe persistent fatigue who are from a region in which Lyme disease is endemic. Clin. Infect. Dis. 18, Suppl 1 (1994) S24-47
24. David, A., A. Pelosi, E. McDonald et al.: Tired, weak, or in need of rest: Fatigue among general practice attenders. BMJ 301 (1990) 1199-11202
25. Deale, A., A. S. David: Chronic fatigue syndrome: Evaluation and management. J. Neuropsychiatry Clin. Neurosci. 6 (1994) 189-194
26. Demitrack, M.A., J. K. Dale, S. E. Straus et al.: Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 73 (1991) 1224-1234
27. Edwards, R.H., H. Gibson, J. E. Clague et al.: Muscle histopathology and physiology in chronic fatigue syndrome. Ciba Found. Symp. 173 (1993) 102-117
28. Fock, R.E., G. F. Krueger, W. A. Nix et al.: Chronisches Erschöpfungssyndrom. Dt. Ärztebl. 91 (1994) 2946-2952
29. Friedberg, F., L. B. Krupp: A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. Clin. Infect. Dis. 18, Suppl 1 (1994) 5105-110
30. Fudenberg, N. H.: Treatment for chronic fatigue syndrome. Am. J. Med. 97 (1994) 493-494
31. Fukuda, K., S. E. Straus, I. Hickie et al.: The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 121 (1994) 953-959
32. Gold, D., R. Bowden, J. Sixbey et al.: Chronic fatigue. A prospective clinical and virologic study. JAMA 264 (1990) 48-53
33. Goodnick, P.J., R. Sandoval: Psychotropic treatment of chronic fatigue syndrome and related disorders. J. Clin. Psychiatry 54 (1993) 13-20
34. Gow, J.W., W. M. Behan, G. B. Clements et al.: Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. Br. Med. J. 302 (1991) 692-696
35. Gray, J. B., A. M. Martinovic: Eicosanoids and essential fatty acid modulation in chronic disease and the chronic fatigue syndrome. Med. Hypotheses 43 (1994) 31-42
36. Gunn, W. J., D. B. Connell, B. Randall: Epidemiology of chronic fatigue syndrome: The Centers for Disease Control Study. Ciba Found. Symp. 173 (1993) 83-93; 93-101
37. Hodel, L., P. J. Grob: Psyche und Immunität. Schweiz. Med. Wochenschr. 123 (1993) 2323-2341
38. Holmes, G. P., J. E. Kaplan, N. M. Gantz et al.: Chronic fatigue syndrome: a working case definition. Ann. Intern. Med. 108 (1988) 387-389
39. Hotopf, M., N. Noah, S. Wessely: Chronic fatigue and minor psychiatric morbidity after viral meningitis: a controlled study. J. Neurol. Neurosurg. Psychiatry 60 (1996) 504-509
40. Jamal, G.A., S. Hansen: Electrophysiological studies in the postviral fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 48 (1985) 691-694
41. Katon, W.J., J. Russo: Chronic fatigue syndrome criteria. A critique of the requirement for multiple physical complaints. Arch. Intern. Med. 152 (1992) 1604-1609
42. Kent-Braun, J.A., K. R. Sharma, M. W. Weiner et al.: Central basis of muscle fatigue in chronic fatigue syndrome. Neurology 43 (1993) 125-131
43. Kroenke, K., D. Wood, D. Mangelsdorff et al.: Chronic fatigue in pimary care: Prevalence, patients characteristics and outcome. JAMA 269 (1988) 929-934
44. LaWrie, S.M., A. J. Pelosi: Chronic fatigue syndrome in the community. Prevalence and associations. Br. J. Psychiatry 166 (1995) 793-797
45. Leese, G., P. Chattington, W. Fraser et al.: Short-term night-shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 81 (1996) 1867-1870
46. Linden,M, W. Maier, M. Achberg et al.: Psychische Erkrankungen und Ihre Behandlung in Allgemeinarztpraxen in Deutschland. Nervenarzt 67 (1996) 205-215
47. Lindh, G., A. Samuelson, K. O. Hedlund et al.: No findings of enteroviruses in Swedish patients with chronic fatigue syndrome. Scand. J. Infect. Dis. 28 (1996) 305-307
48. Lloyd, A.R., S. C. Gandevia, J. P. Hales: Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome. Brain 114 (1991) 85-98
49. Lloyd, A.R., J. P. Hales, S. C. Gandevia: Muscle strength, endurance and recovery in the post-infection fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 51 (1988) 1316-1322
50. Lloyd, A.R., I. Hickie, C. R. Boughton et al.: Prevalence of chronic fatigue syndrome in an australian population. Med. J. Aust. 153 (1990) 522-528
51. Lloyd, A.R., I. Hickie, A. Brockman et al.: Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am. J. Med. 94 (1993) 197-203
52. Lloyd, A., I. Hickie, D. Wakefield et al.: A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am. J. Med. 89 (1990) 561-568
53. Manian, F.A.: Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: Is there evidence of activation of a nonspecific polyclonal immune response? Clin. Infect. Dis. 19 (1994) 448-453
54. Manu, P., D. A. Matthews, T. J. Lane: The mental health of patients with a chief complaint of chronic fatigue. Arch. Intern. Med. 148 (1988) 2213
55. Matthews, D.A., P. Manu, T. J. Lane: Diagnostic beliefs among patients with chronic fatigue. Clin. Res. 37 (1989) 820 A
56. McCully, K. K., B. H. Natelson, S. Iotti et al.: Reduced oxidative muscle metabolism in chronic fatigue syndrome. Muscle & Nerve 19 (1996) 621-625
57. McEvedy, C., A. W. Beard: Concept of benign myalgic encephalomyelitis. BMJ (1970) 11-15
58. McEvedy, C., A. W. Beard: Royal Free epidemic of 1955: a reconsideration. Br. Med. J. (1970) 7-11
59. Moldofsky, H.: Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome. Adv. Neuroimmunol. 5 (1995) 39-56
60. Nakaya, T., H. Takahashi, Y. Nakamura et al.: Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome. FEBS Lett. 378 (1996) 145-149
61. Natelson, B. H., J. M. Cohen, I. Brassloff et. al: A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome. J. Neurol. Sci. 120 (1993) 213-217
62. Nix, W. A.: Das Chronic-Fatigue-Syndrom. Ein neues Krankheitsbild? Nervenarzt 61 (1990) 390-396
63. Nix, W. A.: Das Chronic-Fatigue-Syndrom: Erkrankung des Muskels oder der Seele? Akt. Neurol. 18 (1991) 185-187
64. Nix, W.A.: Erschöpfbarkeit und Umwelterkrankungen. Umweltmed. Forsch. Prax. 1 (1996) 219-220
65. Nix, W. A.: Immer müde- bin ich krank? TRIAS/Thieme, Stuttgart 1996
66. Nix, W. A.: MCS/IEI und CFS. Diagnose Multiple-Chemical-Sensitivity und Chronic-Fatigue-Syndrom. Umweltmed. Forsch. Prax. 1 (1996) 229-238
67. Nix, W. A., S. Fischer, G. Lüder: Quantitative peripheral fatigue investigation in healthy and diseased muscle (abstract). Neurology 41, Suppl 1 (1991) 395
68. Pawlikowska, T., T. Chalder, S. R. Hirsch et al.: Population based study of fatigue and psychological distress. Br. Med. J. 308 (1994) 763-766
69. Peterson, P. K., J. Shepard, M. Macres et al.: A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am. J. Med. 89 (1990) 554-560
70. Powell, R., R. Dolan, S. Wessely: Attributions and self-esteem in depression and chronic fatigue syndromes. J. Psychosom. Res. 34 (1990) 665-673
71. Preedy, V.R., D. G. Smith, J. R. Salisbury et al.: Biochemical and muscle studies in patients with acute onset post-viral fatigue syndrome. J. Clin. Pathol. 46 (1993) 722-726
72. Price, R.K., C. S. North, S. Wessely et al.: Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep. 107 (1992) 514-522
73. Roberts, L., Byrne E.: Single fiber EMG studies in chronic fatigue syndrome: a reappraisal. J. Neurol. Neurosurg. Psychiatry 75 (1994) 375-376
74. Schepank, H.: Psychogene Erkrankungen der Stadtbevölkerung: eine epidemiologische-tiefenpsychologische Feldstudie in Mannheim. Springer, Heidelberg (1987)
75. Schwartz, R. B., B. M. Garada, A. L. Komaroff et al.: Detection of intracranial abnormalities in patients with chronic fatigue syndrome: Comparison of MR imaging and SPECT. Am. J. Roentgenol. 162 (1994) 935-941
76. Schwartz, R. B., A. L Komaroff, B. M. Garada et al.: SPECT imaging of the brain: Comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. Am. J. Roentgenol. 162 (1994) 943-951
77. See, D.M., J. G. Tilles: Alpha-interferon treatment of patients with chronic fatigue syndrome, Immunol. Invest. 25 (1996) 153-164
78. Sharpe, M.C., L. C. Archard, J. E. Banatvala et al.: A report-chronic fatigue syndrome: Guidelines for research. J. R. Soc. Med. 84 (1991) 118-121
79. Sharpe, M. C., K. Hawton, V. Seagroatt et al.: Follow up of patients presenting with fatigue to an infectious diseases clinic. Br. Med. J. 305 (1992) 147-152
80. Straus, S. E., J. K. Dale, M. Tobi et al.: Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N. Engl. J. Med. 319 (1988) 1692-1698
81. Surawy, C., A. Hackmann, K. Hawton et al.: Chronic fatigue syndrome: a cognitive approach. Behav. Res. Ther. 33 (1995) 535-544
82. Swanink, C. M., J. W. van der Meer, J. H. Vercoulen et al.: Epstein-Barr virus (EBV) and the chronic fatigue syndrome: Normal virus load in blood and normal immunologic reactivity in the EBV regression assay. Clin. Infect. Dis. 20 (1995) 1390-1392
83. Swanink, C. M., J. H. Vercoulen, G. Bleijenberg et al.: Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group. J. Intern. Med. 237 (1995) 499-506
84. Taerk, G., W. Gnam: A psychodynamic view of the chronic fatigue syndrome. The role of object relations in etiology and treatment. Gen. Hosp. Psychiatry 16 (1994) 319-325
85. Vercoulen, J. H., C. M. Swanink, J. F. Fennis et al.: Prognosis in chronic fatigue syndrome: a prospective study on the natural course. J. Neurol. Neurosurg. Psychiatry 60 (1996) 489-494
86. Vercoulen, J. H., C. M. Swanink, F. G. Zitman et al.: Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347 (1996) 858-861
87. Walker, E. A., W. J. Katon, R. P. Jemelka: Psychiatric disorders and medical care utilization among people in the general population who report fatigue. J. Gen. Intern. Med. 8 (1993) 436-440
88. Ware, N.C., A. Kleinman: Culture and somatic experience: the social course of illness in neurasthenia and chronic fatigue syndrome. Psychosom. Med. 54 (1992) 546-560
89. Wessely, S., T. Chalder, S. Hirsch et al.: Postinfectious fatigue: prospective cohort study in primary care. Lancet 345 (1995) 1333-1338
90. Wessely, S., R. Powell: Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders. J. Neurol. Neurosurg. Psychiatry 52 (1989) 940-948
91. White, P.D., J. M. Thomas, J. Amess et al.: The existence of a fatigue syndrome after glandular fever. Psychol. Med. 25 (1995) 907-916
92. Wilson, A., I. Hickie, A. Lloyd et al.: Longitudinal study of outcome of chronic fatigue syndrome. Br. Med. J. 308 (1994) 756-759
93. Wong, R., G. Lopaschuk, G. Zhu et al.: Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31 P nuclear magnetic resonance spectroscopy. Chest 102 (1992) 1716-1722
94. Woodward, R. V., D. H. Broom, D. G. Legge: Diagnosis in chronic illness: disabling or enabling-the case of chronic fatigue syndrome. J. R. Soc. Med. 88 (1995) 325-329